Loss of MutL Disrupts CHK2-Dependent Cell-Cycle Control through CDK4/6 to Promote Intrinsic Endocrine Therapy Resistance in Primary Breast Cancer.

Name: Loss of MutL Disrupts CHK2-Dependent Cell-Cycle Control through CDK4/6 to Promote Intrinsic Endocrine Therapy Resistance in Primary Breast Cancer.
Author: Haricharan, Svasti

Loss of MutL Disrupts CHK2-Dependent Cell-Cycle Control through CDK4/6 to Promote Intrinsic Endocrine Therapy Resistance in Primary Breast Cancer. — المؤلف: Haricharan, Svasti — Cancer discovery 20180521

المؤلف: Haricharan, Svasti
النشر: Cancer discovery 20180521
الوصف: 1168-1183 p.
الموضوعات: Animals؛ Aromatase Inhibitors؛ Breast Neoplasms؛ Cell Cycle؛ Cell Line, Tumor؛ Checkpoint Kinase 2؛ Cyclin-Dependent Kinase 4؛ Cyclin-Dependent Kinase 6